Contact
Please use this form to send email to PR contact of this press release:
UPDATE -- Cantabio Pharmaceuticals and University of Antioquia Collaborate to Research Company’s Therapeutic Candidates Targeting DJ-1 Protein to Treat Parkinson’s Disease
TO: